Jinling Pharmaceutical Co Ltd (000919) — Cash Flow-to-Debt Ratio
Jinling Pharmaceutical Co Ltd (000919) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥74.01 Million could theoretically repay 0% of its total liabilities (CN¥1.18 Billion) in one year. See 000919 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jinling Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Jinling Pharmaceutical Co Ltd across 26 annual periods. Also explore Jinling Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year debt coverage analysis for Jinling Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Jinling Pharmaceutical Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | CN¥154.19 Million | CN¥1.24 Billion | ▼ -32.3% |
| 2023 | 0.18x | CN¥158.92 Million | CN¥865.58 Million | ▼ -35.4% |
| 2022 | 0.28x | CN¥260.59 Million | CN¥916.30 Million | ▼ -11.1% |
| 2021 | 0.32x | CN¥292.03 Million | CN¥913.10 Million | ▼ -12.7% |
| 2020 | 0.37x | CN¥311.46 Million | CN¥850.43 Million | ▼ -42.3% |
| 2019 | 0.63x | CN¥465.85 Million | CN¥733.62 Million | ▼ -6.5% |
| 2018 | 0.68x | CN¥433.83 Million | CN¥638.90 Million | ▲ +23.1% |
| 2017 | 0.55x | CN¥443.11 Million | CN¥803.11 Million | ▲ +361.9% |
| 2016 | 0.12x | CN¥96.15 Million | CN¥804.90 Million | ▼ -47.9% |
| 2015 | 0.23x | CN¥212.45 Million | CN¥925.73 Million | ▼ -33.3% |
| 2014 | 0.34x | CN¥299.89 Million | CN¥871.24 Million | ▼ -7.4% |
| 2013 | 0.37x | CN¥271.21 Million | CN¥729.94 Million | ▲ +17.4% |
| 2012 | 0.32x | CN¥232.12 Million | CN¥733.12 Million | ▲ +16.0% |
| 2011 | 0.27x | CN¥172.82 Million | CN¥633.01 Million | ▼ -16.4% |
| 2010 | 0.33x | CN¥177.81 Million | CN¥544.47 Million | ▼ -30.6% |
| 2009 | 0.47x | CN¥188.41 Million | CN¥400.59 Million | ▼ -50.0% |
| 2008 | 0.94x | CN¥305.26 Million | CN¥324.25 Million | ▲ +232.4% |
| 2007 | 0.28x | CN¥118.06 Million | CN¥416.86 Million | ▼ -32.4% |
| 2006 | 0.42x | CN¥138.50 Million | CN¥330.39 Million | ▲ +7.6% |
| 2005 | 0.39x | CN¥109.29 Million | CN¥280.42 Million | ▼ -21.3% |
| 2004 | 0.50x | CN¥159.81 Million | CN¥322.83 Million | ▼ -21.7% |
| 2003 | 0.63x | CN¥161.86 Million | CN¥256.06 Million | ▲ +43.9% |
| 2002 | 0.44x | CN¥130.36 Million | CN¥296.79 Million | ▲ +45.6% |
| 2001 | 0.30x | CN¥92.49 Million | CN¥306.54 Million | ▼ -79.0% |
| 2000 | 1.43x | CN¥231.31 Million | CN¥161.37 Million | ▲ +452.4% |
| 1999 | 0.26x | CN¥39.77 Million | CN¥153.24 Million | — |